Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) Research & Development (2021 - 2025)

Historic Research & Development for Nexgel (NXGL) over the last 5 years, with Q3 2025 value amounting to $7000.0.

  • Nexgel's Research & Development changed N/A to $7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8000.0, marking a year-over-year decrease of 9120.88%. This contributed to the annual value of $78000.0 for FY2024, which is 2427.18% down from last year.
  • Latest data reveals that Nexgel reported Research & Development of $7000.0 as of Q3 2025.
  • In the past 5 years, Nexgel's Research & Development registered a high of $193000.0 during Q3 2022, and its lowest value of $1000.0 during Q1 2025.
  • In the last 5 years, Nexgel's Research & Development had a median value of $13500.0 in 2021 and averaged $39142.9.
  • Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 101000.0% in 2022, then plummeted by 9689.12% in 2023.
  • Over the past 5 years, Nexgel's Research & Development (Quarter) stood at $14000.0 in 2021, then skyrocketed by 1278.57% to $193000.0 in 2022, then plummeted by 93.26% to $13000.0 in 2023, then surged by 484.62% to $76000.0 in 2024, then crashed by 90.79% to $7000.0 in 2025.
  • Its last three reported values are $7000.0 in Q3 2025, $1000.0 for Q1 2025, and $76000.0 during Q2 2024.